Laurent Pharmaceuticals Inc.

This study tested an oral medication called LAU-7b in 272 adults with Long COVID who had moderate to severe symptoms lasting at least 12 weeks after their COVID-19 infection. The goal was to see if the drug could improve physical function and reduce symptoms compared to a placebo…